Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative
US12378234B2 · kind B2 · utility
0Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2020 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jun 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates generally to crystalline polymorphs of a thiazolylpyrazole derivative, pharmaceutical compositions comprising them, and methods of using the crystalline polymorphs and their compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.